ANGO reported an adjusted loss per share of 3 cents for fourth-quarter fiscal 2025, narrower than the year-ago quarter’s ...

Fintel reports that on July 16, 2025, Lake Street initiated coverage of AngioDynamics (NasdaqGS:ANGO) with a Buy ...

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q4 2025 earnings on Jul 15, 2025. The consensus estimate for Q4 2025 ...

AngioDynamics Inc (ANGO) reports a robust 12% revenue increase, driven by Med Tech advancements, despite facing tariff impacts.

AngioDynamics expects full-year results to range from a loss of 35 cents per share to a loss of 25 cents per share, with revenue in the range of $305 million to $310 million. AngioDynamics shares have ...

Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

In the latest market close, AngioDynamics (ANGO) reached $6.09, with a -0.98% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.57% for the ...

AngioDynamics' NanoKnife FDA clearance boosts its potential in cancer treatment. Read why ANGO stock is a buy with its growth trajectory.

ANGIODYNAMICS ($ANGO) is expected to release its quarterly earnings data on Wednesday, April 2nd before market open, per Finnhub. Analysts are expecting revenue of $71,709,060 and earnings of -$0. ...